First Time Loading...

ImExHS Ltd
ASX:IME

Watchlist Manager
ImExHS Ltd Logo
ImExHS Ltd
ASX:IME
Watchlist
Price: 0.57 AUD Market Closed
Updated: Apr 29, 2024

Wall Street
Price Targets

IME Price Targets Summary
ImExHS Ltd

Wall Street analysts forecast IME stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IME is 1.53 AUD with a low forecast of 1.52 AUD and a high forecast of 1.58 AUD.

Lowest
Price Target
1.52 AUD
166% Upside
Average
Price Target
1.53 AUD
168% Upside
Highest
Price Target
1.58 AUD
176% Upside
ImExHS Ltd Competitors:
Price Targets
AUGX
Augmedix Inc
114% Upside
EVH
Evolent Health Inc
65% Upside
SECT B
Sectra AB
31% Downside
MDR
Medadvisor Ltd
39% Upside
263700
Carelabs Co Ltd
203% Upside
GDRX
Goodrx Holdings Inc
24% Upside
HSTM
HealthStream Inc
26% Upside
688246
Goodwill E-Health Info Co Ltd
70% Upside

Revenue
Forecast

Revenue Estimate
ImExHS Ltd

For the last 8 years the compound annual growth rate for ImExHS Ltd's revenue is 90%. The projected CAGR for the next 3 years is 23%.

90%
Past Growth
23%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
ImExHS Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
6%
Average Beat

Net Income
Forecast

Net Income Estimate
ImExHS Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is IME's stock price target?
Price Target
1.53 AUD

According to Wall Street analysts, the average 1-year price target for IME is 1.53 AUD with a low forecast of 1.52 AUD and a high forecast of 1.58 AUD.

What is ImExHS Ltd's Revenue forecast?
Projected CAGR
23%

For the last 8 years the compound annual growth rate for ImExHS Ltd's revenue is 90%. The projected CAGR for the next 3 years is 23%.